Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Benjamin J R BuckleyDeirdre A LanePeter CalvertJuqian ZhangDavid G GentC Daniel MullinsPaul DorianShun KohsakaStefan H HohnloserGregory Yoke Hong LipPublished in: Journal of clinical medicine (2022)
Apixaban was associated with a better overall safety and effectiveness profile compared to VKAs and other DOACs.